Efficient and Innovative Natural History Studies in Rare Diseases
Programme note: RFA-FD-25-017
FDA Office of Orphan Products Development
Shared attributes
- Jurisdiction: United States
- Funding type: Grant
- Area: Rare disease
Funding Atlas programme
Programme note: RFA-FD-25-020, R01
FDA Office of Orphan Products Development
Documented facts
Source-bound timeline
These dates were recorded in the Atlas as of 3 October 2026. Confirm current timing with the funder.